drugset / Trial / NCT00662558

A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain

NCT00662558 ↗

Phase 3 Completed 802 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the analgesic effectiveness of celecoxib and tramadol in subjects with Chronic Low Back Pain measured by the Numerical Rating Scale (NRS-Pain) at Week 6

Timeline

Start
2008-01
Primary completion
2008-09
Completion
2008-09

Outcome

Met primary endpoint

registry analysis (unspecified test); Celecoxib vs Tramadol HCL; Risk Difference (RD) 0.0910 (95% CI 0.0255 to 0.1565) NCT00662558 ↗

registry analysis (unspecified test); Celecoxib vs Tramadol HCL; p = 0.008; Cochran-Mantel-Haenszel NCT00662558 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg —
Comparator Tramadol Other / unclassified 50 mg —

Indications

No indication recorded.